D16 Pharma & Biotec Ltd. is Bangladesh’s youngest yet highly progressive research based pharmaceutical marketing company involved in research, marketing of branded pharmaceutical and biotech formulations. The product portfolio includes highly innovative prescription products in important therapeutic areas like cardiovascular disease, Hepatology and rheumatology, anti-HIV and gastro-intestinal care products.
D16 Pharma & Biotec will always focus on contributing to disease prevention and reducing the mortality.
Research efforts is a great strength of D16 Pharma & Biotec. The main research areas will be New Chemical Entities (NCE), New Biological Entities (NBE) Novel Drug Delivery System (NDDS) based pharmaceutical formulations, Novel peptides & human monoclonal antibodies and Vaccine development.
D16 Pharma & Biotec has collaborated with Inviragen for developing and commercializing Dengue and JE vaccine.
D16 Pharma and Biotec has established a countrywide sales and marketing network in Bangladesh through a vibrant sales force and highly motivated marketing and sales professionals and efficient logistic network.
D16 Pharma and Biotec partnered with UniHealth and UniMed for manufacturing its products.
D16 Pharma & Biotec is a bright spot in the pharmaceutical industry in Bangladesh not just because of what we do, but in the way we do it. If you are looking for a company where you can change a life, make a dream come true, and light the way for a better tomorrow, 016 is the place where you can shine. We offer a different kind of work culture. A high standard of ethics is mandatory, knowledge is our pledge, diversity is valued, individual initiative is rewarded.